Bodybuilders and others who wish to boost muscle growth can use Dindolyl Methane (or DIM). Recent research has shown that DIM could pose health risks. DIM can cause liver damage if taken in excess. Kidney damage can also be an issue, and could lead to kidney failure. The long-term health risks of DIM cause many bodybuilders and athletes think about the question: should I use supplements with DIM?
To boost testosterone production the majority of people take diindolylmethane supplemental. It is well-known that testosterone functions as an androgen. This means that it can cause hormonal changes within the tissues. DIM has been shown in studies to mimic the effects of testosterone, along with other hormones. Because men produce much more testosterone than women do, some manufacturers have added diindolylmethane to their products in order to make them more competitive in male circles. The idea is that men will react to a product that mimics the effects of testosterone naturally produced.
Many companies market DIM as a tumor-suppressor. While diindolylmethane has been proven effective in reducing the growth of tumors in laboratory animals it was given orally to the animals. In order for humans to experience the same effect diindolylmethane needs to be taken in large doses for a long duration. In addition, while the animals studied remained cancer free for several years but all of them developed liver disease at some point, possibly due to too much diindolylmethane being present in their bodies. To get a real look at the way DIM is affecting the body, you should consult a physician.
The only way to prove that DIM is effective in treating breast carcinoma is to conduct an experiment in which cells from healthy breast cells are exposed to high doses of diindolylmethane over a prolonged period of time. There are pros and negatives to using DIM just like every chemical. The ability to mimic hormones is one of the advantages. This allows you to make insulin which can inhibit cancer cell growth. The downsides are that diindolylmethane also produces an extremely harmful chemical known as DMSO. Learn more about diindolylmethane for men now.
One of the most common claims made for diindolylmethane as an option for treating different health issues is that it acts as a natural, anti-fungal, anti-bacterial and anti-cancer drug. The National Institute of Health, through an exhaustive study of supporting data concluded that there was no evidence to support these claims. According to the Institute of Chemical Technology, there were no studies conducted to prove this assertion. The Institute of Chemical Safety, conducting an in-depth study of the safety profile of the firestone concluded that the information provided by pharmaceutical companies regarding the benefits of diindolylmethane for humans was not completely reliable.
In the May 2021 issue of the Journal of Toxicology and Environmental Health, van der Goes, et al. pointed out numerous potential hazards related to the use of diindolylmethane, including allergic reactions, skin rash, asthma attacks, dizziness, headaches, and respiratory issues. They also noted that the recommended daily allowance for this chemical is 0.2 milligrams or one 10th of one teaspoon. It is not known what the concentration is when this chemical is paired with other compounds. This substance is not considered safe since it hasn’t been thoroughly test.
The abstract of the view indicates that the use of diindolylmethane (DIEM) in the context of treating cancer is based on the concept of inhibiting the intracellular inhibition of pyruvate metabolite through flavenoids, and thereby stopping the accumulation of oxalates within renal tubule cells as well as adenine granulocytes. The drug metabiplicate toxicology studies have not demonstrated that this chemical could cause overdose. The Food and Drug Administration approved this substance as a prescription drug in June 1996. According to the FDA the manufacturer of firestone Tincture is currently conducting two major trials in Europe and the United States.
The view abstract also shows that diindolylmethane’s usage in the treatment of cancer is based on the idea of inhibiting intracellular inhibition by flavenoids that regulate pyruvate metabolism and thus stopping the accumulation of adenine and oxalates in the renal tubule cells. However, the drug metabiplicate studies failed to provide evidence convincing that consumption of this chemical can cause an overdose. The Food and Drug Administration approved this substance as a prescribed drug in June 1996. According to the FDA, the manufacturer of firestone tincture is in the process of completing two major trials–one in Europe and another in the United States. According to FDA, the FDA states that the maker of firestone Tincture is currently completing two major trials in Europe as well as one in the United States.